Chrysea Announces Collaboration with Mount Sinai to Study Sprevive® Dose Levels in Humans

CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ -- • An early-phase ...